This serological profile aligns with other rare reports where anti-CNTN1 antibodies are present in patients with CIDP and MN, suggesting a distinct antibody-mediated mechanism separate from typical PLA2R-associated MN [6]. This evidence concerns the gene CNTN1 and chronic inflammatory demyelinating polyradiculoneuropathy.